Universe Pharmaceuticals Inc

Universe Pharmaceuticals Inc

Universe Pharmaceuticals Inc (UPC) is a very small-cap pharmaceutical company with a market capitalisation of about $2.96 million. For most investors this indicates high speculative risk: shares may be thinly traded, subject to large percentage moves, and sensitive to news flow about clinical data, regulatory milestones or financing. Small pharmas often rely on limited revenue, partnerships or milestone payments, and may need to raise capital, which can dilute shareholders. Key considerations include the company’s drug pipeline (if any), cash runway, management track record and intellectual property position. Because public information on microcaps can be sparse, investors should check official filings and be prepared for volatility and setbacks. This is educational information only and not personalised investment advice; microcap pharma stocks are generally suitable only for investors who understand high risk and potential loss of capital.

Stock Performance Snapshot

Above Average

Financial Health

Universe Pharmaceuticals is generating good revenue and cash flow, showing a solid financial position.

Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.

Baskets Featuring UPC

China's Biopharma Innovators: The Next Global Partnership Wave

China's Biopharma Innovators: The Next Global Partnership Wave

Following GSK's major licensing deal with China's Jiangsu Hengrui, a new investment theme is emerging around Chinese pharmaceutical innovators. This theme focuses on other Chinese biopharma companies that are likely to attract similar global partnerships, driving value through their advanced drug development pipelines.

Published: July 28, 2025

Explore Basket

Why You’ll Want to Watch This Stock

📈

Tiny market cap

At roughly $3M market value, UPC is a microcap — movements can be large and trading thin, so price swings may be rapid and unpredictable.

Pipeline & regulation

Pharmaceutical value often hinges on clinical and regulatory milestones; positive data can lift sentiment, but failures can be costly.

🌍

Liquidity & news

With limited publicly available information, news and filings can drive big moves; perform careful due diligence and be aware of dilution risk.

Why invest with Nemo?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions